Background This systematic review and meta-analysis aimed to investigate the clinical
efficacy and safety of systemic corticosteroids in the treatment of patients with severe …

Severe community-acquired pneumonia is the most life-threatening form of community-
acquired pneumonia, characterised by intensive care unit admission and high morbidity and …

Background Whether the antiinflammatory and immunomodulatory effects of glucocorticoids
may decrease mortality among patients with severe community-acquired pneumonia is …

Purpose Severe community-acquired pneumonia (sCAP) is associated with high morbidity
and mortality, and whilst European and non-European guidelines are available for …

Background Community-acquired pneumonia (CAP) is a leading cause of morbidity and
mortality. Corticosteroids may be a beneficial adjunct in the treatment of bacterial …

Importance Community-acquired pneumonia (CAP) results in approximately 1.4 million
emergency department visits, 740 000 hospitalizations, and 41 000 deaths in the US …

Introduction International guidelines provide heterogenous guidance on use of
corticosteroids for community-acquired pneumonia (CAP). Methods We performed a …

The understanding of acute respiratory distress syndrome (ARDS) has evolved greatly since
it was first described in a 1967 case series, with several subsequent updates to the definition …

Background Community-acquired pneumonia (CAP) is associated with high morbidity and
mortality. In the present study, we aimed to assess the effect of corticosteroids on all-cause …

Background The role of corticosteroids in the treatment of community-acquired pneumonia
(CAP) remains uncertain. We conducted an updated meta-analysis to investigate the …